These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34332093)

  • 1. Positron emission tomographic imaging in drug discovery.
    Ghosh KK; Padmanabhan P; Yang CT; Ng DCE; Palanivel M; Mishra S; Halldin C; Gulyás B
    Drug Discov Today; 2022 Jan; 27(1):280-291. PubMed ID: 34332093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography in CNS drug discovery and drug monitoring.
    Piel M; Vernaleken I; Rösch F
    J Med Chem; 2014 Nov; 57(22):9232-58. PubMed ID: 25144329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of positron emission tomography (PET) imaging in CNS drug development.
    Suridjan I; Comley RA; Rabiner EA
    Brain Imaging Behav; 2019 Apr; 13(2):354-365. PubMed ID: 30259405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET).
    Gomes PMO; Silva AMS; Silva VLM
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32283680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemistry Considerations for the Clinical Translation of Oncology PET Radiopharmaceuticals.
    Allott L; Aboagye EO
    Mol Pharm; 2020 Jul; 17(7):2245-2259. PubMed ID: 32433888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational Model-Informed Dose Selection for a Human Positron Emission Tomography Imaging Study of JNJ-54175446, a P2X7 Receptor Antagonist.
    Xu Y; Miao X; Ravenstijn P; Hijzen A; Schmidt ME; Nandy P; Zhou H
    Clin Transl Sci; 2020 Mar; 13(2):309-317. PubMed ID: 31642608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET as a Translational Tool in Drug Development for Neuroscience Compounds.
    Varrone A; Bundgaard C; Bang-Andersen B
    Clin Pharmacol Ther; 2022 Apr; 111(4):774-785. PubMed ID: 35201613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational PET imaging research.
    Hargreaves RJ; Rabiner EA
    Neurobiol Dis; 2014 Jan; 61():32-8. PubMed ID: 24055214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent applications of positron emission tomographic (PET) imaging in psychiatric drug discovery.
    Zimmer L
    Expert Opin Drug Discov; 2024 Feb; 19(2):161-172. PubMed ID: 37948046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emitting tracers in pre-clinical drug development.
    Fernandes E; Barbosa Z; Clemente G; Alves F; Abrunhosa AJ
    Curr Radiopharm; 2012 Apr; 5(2):90-8. PubMed ID: 22280107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridging the gaps in
    Campbell MG; Mercier J; Genicot C; Gouverneur V; Hooker JM; Ritter T
    Nat Chem; 2016 Dec; 9(1):1-3. PubMed ID: 27995923
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative PET Imaging in Drug Development: Estimation of Target Occupancy.
    Naganawa M; Gallezot JD; Rossano S; Carson RE
    Bull Math Biol; 2019 Sep; 81(9):3508-3541. PubMed ID: 29230702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PET imaging for better understanding of normal and pathological neurotransmission].
    Zimmer L
    Biol Aujourdhui; 2019; 213(3-4):109-120. PubMed ID: 31829931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET technology for drug development in psychiatry.
    Arakawa R; Takano A; Halldin C
    Neuropsychopharmacol Rep; 2020 Jun; 40(2):114-121. PubMed ID: 32463584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of PET data in CNS drug discovery and development.
    Varnäs K; Varrone A; Farde L
    J Pharmacokinet Pharmacodyn; 2013 Jun; 40(3):267-79. PubMed ID: 23660778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microwave accelerated labeling methods in the synthesis of radioligands for positron emission tomography imaging.
    Kallmerten AE; Alexander A; Wager KM; Jones GB
    Curr Radiopharm; 2011 Oct; 4(4):343-54. PubMed ID: 22202157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging in Central Nervous System Drug Discovery.
    Gunn RN; Rabiner EA
    Semin Nucl Med; 2017 Jan; 47(1):89-98. PubMed ID: 27987561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging metabotropic glutamate receptor system: Application of positron emission tomography technology in drug development.
    Xu Y; Li Z
    Med Res Rev; 2019 Sep; 39(5):1892-1922. PubMed ID: 30740744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Exposition of
    Saxena P; Mahmood T; Dixit M; Gambhir S; Ahsan F
    Curr Radiopharm; 2021; 14(2):92-100. PubMed ID: 33261547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.